Cargando…

Retrospective investigation of combination therapy with clarithromycin and levofloxacin for pulmonary Mycobacterium avium complex disease

BACKGROUND: Fluoroquinolones are often used for the treatment of refractory Mycobacterium avium complex (MAC) disease when the clinical efficacy of the recommended regimen, which includes clarithromycin (CAM), rifampicin (RFP), and ethambutol (EB), is insufficient. However, recent in vitro and in vi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shimomura, Hitoshi, Ono, Airi, Imanaka, Keiko, Majima, Toru, Masuyama, Hidenori, Sato, Tsugumichi, Aoyama, Takao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4728750/ https://www.ncbi.nlm.nih.gov/pubmed/26819735 http://dx.doi.org/10.1186/s40780-015-0025-4

Ejemplares similares

Serum concentrations of clarithromycin and rifampicin in pulmonary Mycobacterium avium complex disease: long-term changes due to drug interactions and their association with clinical outcomes
por: Shimomura, Hitoshi, et al.
Publicado: (2015)

Treatment Outcome of Combination Therapy Including Clarithromycin for Mycobacterium avium Complex Pulmonary Disease
por: Kim, Eun Young, et al.
Publicado: (2011)

A Novel Approach to Extensive Clarithromycin- Resistant Mycobacterium avium Complex Pulmonary Disease
por: Togo, Takeo, et al.
Publicado: (2021)

813. Combination of N-Acetyl-Cysteine With Clarithromycin Against Mycobacterium avium Infection
por: Shiozawa, Ayako, et al.
Publicado: (2018)

Analysis of drug treatment outcome in clarithromycin-resistant Mycobacterium avium complex lung disease
por: Kadota, Tsukasa, et al.
Publicado: (2016)

Azithromycin: A promising treatment option for Mycobacterium avium complex pulmonary disease in case of intolerance to clarithromycin
por: Oshima, Kengo, et al.
Publicado: (2021)

Multidrug Antibiotic Therapy for a Non-Human Immunodeficiency Virus-Infected Patient With Clarithromycin-Resistant Disseminated Mycobacterium avium Complex Disease
por: Kawamura, Ai, et al.
Publicado: (2021)

Comparison of levofloxacin versus clarithromycin efficacy in the eradication of Helicobacter pylori infection
por: Haji-Aghamohammadi, Ali Akbar, et al.
Publicado: (2016)

Variability in Prevalence of Helicobacter pylori Strains Resistant to Clarithromycin and Levofloxacin in Southern Poland
por: Karczewska, Elżbieta, et al.
Publicado: (2012)

The Comparison of Levofloxacin- and Clarithromycin-Based Bismuth Quadruple Therapy Regimens in Helicobacter pylori Eradication
por: Arj, Abbas, et al.
Publicado: (2020)

Phenotype and Molecular Detection of Clarithromycin and Levofloxacin Resistance in Helicobacter pylori Clinical Isolates in Beijing
por: Lok, Chong-Hou, et al.
Publicado: (2020)

Combined administration of rifampicin, ethambutol, and clarithromycin for the treatment of tenosynovitis of the hand caused by Mycobacterium avium complex: Case series and literature review
por: Kaji, Yoshio, et al.
Publicado: (2021)

A Rapid Screening Assay for Clarithromycin-Resistant Mycobacterium avium Complex Using Melting Curve Analysis with Nonfluorescent Labeled Probes
por: Aoki, Akira, et al.
Publicado: (2023)

Evaluation of multiplex ARMS-PCR for detection of Helicobacter pylori mutations conferring resistance to clarithromycin and levofloxacin
por: Li, Yangxia, et al.
Publicado: (2020)

Mycobacterium avium pleuritis with multiple nodules in the pleura
por: Ogata, Hiroaki, et al.
Publicado: (2020)

Pleuroparenchymal fibroelastosis in mycobacterium avium complex lung disease
por: Sugino, Keishi, et al.
Publicado: (2023)

Levofloxacin based vs clarithromycin based sequential therapy in helicobacter pylori eradication; a randomized clinical trial
por: Moradniani, Mosayeb, et al.
Publicado: (2018)

Current status of Helicobacter pylori resistance to Clarithromycin and Levofloxacin in Malaysia—findings from a molecular based study
por: Puah, Suat Moi, et al.
Publicado: (2021)

Levofloxacin versus clarithromycin for Helicobacter pylori eradication: are 14 day regimens better than 10 day regimens?
por: Azab, Eman T., et al.
Publicado: (2022)

A comparative study of Mycobacterium avium subsp. avium and Mycobacterium avium subsp. hominissuis in experimentally infected pigs
por: Agdestein, Angelika, et al.
Publicado: (2012)

Genomic homogeneity between Mycobacterium avium subsp. avium and Mycobacterium avium subsp. paratuberculosis belies their divergent growth rates
por: Bannantine, John P, et al.
Publicado: (2003)

Levofloxacin-containing versus Clarithromycin-containing Therapy for Helicobacter pylori Eradication: A Prospective Randomized Controlled Clinical Trial
por: Sebghatollahi, Vahid, et al.
Publicado: (2018)

High primary resistance to metronidazole and levofloxacin, and a moderate resistance to clarithromycin in Helicobacter pylori isolated from Karnataka patients
por: Shetty, Vignesh, et al.
Publicado: (2019)

Mutations in the Antibiotic Target Genes Related to Clarithromycin, Metronidazole and Levofloxacin Resistance in Helicobacter pylori Strains from Children in China
por: Zhang, Yanyi, et al.
Publicado: (2020)

Molecular Characterization and Mutational Analysis of Clarithromycin- and Levofloxacin-Resistance Genes in Helicobacter pylori from Gastric Biopsies in Southern Croatia
por: Šamanić, Ivica, et al.
Publicado: (2023)

Inducible and Acquired Clarithromycin Resistance in the Mycobacterium abscessus Complex
por: Rubio, Marc, et al.
Publicado: (2015)

Omadacycline Potentiates Clarithromycin Activity Against Mycobacterium abscessus
por: Bich Hanh, Bui Thi, et al.
Publicado: (2021)

Treatment of Mycobacterium avium Complex Pulmonary Disease
por: Kwon, Yong-Soo, et al.
Publicado: (2019)

Response to “Levofloxacin-containing versus Clarithromycin-containing Therapy for Helicobacter pylori Eradication: A Prospective Randomized Controlled Clinical Trial”
por: Patil, Anant D
Publicado: (2018)

Helicobacter pylori Primary and Secondary Genotypic Resistance to Clarithromycin and Levofloxacin Detection in Stools: A 4-Year Scenario in Southern Italy
por: Losurdo, Giuseppe, et al.
Publicado: (2020)

Comparison of the Diagnostic Performance of qPCR, Sanger Sequencing, and Whole-Genome Sequencing in Determining Clarithromycin and Levofloxacin Resistance in Helicobacter pylori
por: Egli, Konrad, et al.
Publicado: (2020)

Development and Validation of Multiplex Quantitative PCR Assay for Detection of Helicobacter pylori and Mutations Conferring Resistance to Clarithromycin and Levofloxacin in Gastric Biopsy
por: Binmaeil, Hasyanee, et al.
Publicado: (2021)

1654. Evaluation of a rapid detection method of clarithromycin resistance genes in Mycobacterium avium using the Amplification Refractory Mutation System-Loop-Mediated Isothermal Amplification method
por: Inagaki, Takayuki, et al.
Publicado: (2020)

Consolidations in Nodular Bronchiectatic Mycobacterium Avium Complex Lung Disease: Mycobacterium Avium Complex or Other Infection?
por: Im, Soo Ah, et al.
Publicado: (2010)

Mycobacterium kansasii Subtype I Is Associated With Clarithromycin Resistance in China
por: Li, Yanming, et al.
Publicado: (2016)

Vancomycin and Clarithromycin Show Synergy against Mycobacterium abscessus In Vitro
por: Mukherjee, Devika, et al.
Publicado: (2017)

The Contribution of Efflux Pumps in Mycobacterium abscessus Complex Resistance to Clarithromycin
por: Vianna, Júlia S., et al.
Publicado: (2019)

Mycobacterium shinjukuense infection successfully treated with clarithromycin, rifampicin, and ethambutol
por: Nakamura, Kayo, et al.
Publicado: (2023)

Rifaximin potentiates clarithromycin against Mycobacterium abscessus in vitro and in zebrafish
por: Goh, Boon Chong, et al.
Publicado: (2023)

Investigating in vivo Mycobacterium avium subsp. paratuberculosis microevolution and mixed strain infections
por: Byrne, Alexander, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_krl2pe99ad4e63kt4de6r3m4vp